These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

946 related items for PubMed ID: 15596670

  • 1. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM, Vives M, Esquerda A, Salud A, Pérez B, Rodríguez-Panadero F.
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions.
    Hsieh TC, Huang WW, Lai CL, Tsao SM, Su CC.
    Cancer Cytopathol; 2013 Sep; 121(9):483-8. PubMed ID: 23408492
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma.
    Paganuzzi M, Onetto M, Marroni P, Filiberti R, Tassara E, Parodi S, Felletti R.
    Chest; 2001 Apr; 119(4):1138-42. PubMed ID: 11296181
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
    Salama G, Miédougé M, Rouzaud P, Mauduyt MA, Pujazon MC, Vincent C, Carles P, Serre G.
    Br J Cancer; 1998 Apr; 77(3):472-6. PubMed ID: 9472646
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion.
    Wagner IC, Guimarães MJ, da Silva LK, de Melo FM, Muniz MT.
    J Bras Pneumol; 2007 Apr; 33(2):185-91. PubMed ID: 17724538
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions.
    Porcel JM, Salud A, Vives M, Esquerda A, Rodríguez-Panadero F.
    Clin Biochem; 2005 Nov; 38(11):1031-3. PubMed ID: 15925354
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
    Feng M, Zhu J, Liang L, Zeng N, Wu Y, Wan C, Shen Y, Wen F.
    Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
    [Abstract] [Full Text] [Related]

  • 20. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS, Cheng BC, Ge W, Gao JF.
    Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.